ArticleStatistics in medicine2025
BayTetra: A Bayesian Semiparametric Approach for Testing Trajectory Differences.
Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Modeling Alzheimer's Disease Biomarkers' Trajectory in the Absence of a Gold Standard Using a Bayesian Approach.Statistics in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Testing differences in longitudinal trajectories among distinct groups of population is an important task in many biomedical applications. Motivated by an application in Alzheimer's disease, we develop BayTetra, an innovative Bayesian semiparametric approach for estimating and testing group differences in multivariate longitudinal trajectories. BayTetra jointly models multivariate longitudinal data by directly accounting for correlations among different responses, and uses a semiparametric framework based on B-splines to capture the non-linear trajectories with great flexibility. To avoid overfitting, BayTetra encourages parsimonious trajectory estimation by imposing penalties on the smoothness of the spline functions. The proposed method converts the challenging task of hypothesis testing for longitudinal trajectories into a more manageable equivalent form based on hypothesis testing for spline coefficients. More importantly, by leveraging posterior inference with natural uncertainty quantification, our Bayesian method offers a more robust and straightforward hypothesis testing procedure than frequentist methods. Extensive simulations demonstrate BayTetra's superior performance over alternatives. Applications to the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) study yield interpretable and valuable clinical insights. A major contribution of this paper is that we have developed an R package BayTetra, which implements the proposed Bayesian semiparametric approach and is the first publicly available software for hypothesis testing on trajectory differences based on a flexible modeling framework.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.